Enzan, N., Matsushima, S., Ide, T., Kaku, H., Higo, T., Tsuchihashi‐Makaya, M., & Tsutsui, H. (2020). Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction. ESC Heart Fail.
Citação norma ChicagoEnzan, Nobuyuki, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Taiki Higo, Miyuki Tsuchihashi‐Makaya, and Hiroyuki Tsutsui. "Spironolactone Use Is Associated With Improved Outcomes in Heart Failure With Mid‐range Ejection Fraction." ESC Heart Fail 2020.
Deismireacht MLAEnzan, Nobuyuki, et al. "Spironolactone Use Is Associated With Improved Outcomes in Heart Failure With Mid‐range Ejection Fraction." ESC Heart Fail 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.